Fuse Oncology, Inc. announced that they are working toward building an end-to-end workflow at the ASTRO26 conference.
Public source
Publisher name
Public post
#ASTRO26 is right around the corner, and we're really excited about this one. Last year we told you we were working toward building an end-to-end workflow. This year...…
Company
Fuse Oncology, Inc.
Care at the speed of the patient
- Industry
- Software Development
- Location
- Boone, US
- Company size
- 11–50 employees
About Fuse Oncology, Inc.
Here at Fuse, we’re building a seamless future for radiation oncology. Our AI-powered tools automate time-consuming tasks like documentation and charge capture, so clinicians can focus on what matters most: the patient. Built by clinical leaders and backed by real results, Fuse blends smart automation with expert support to streamline workflows, reduce burnout, and deliver care at the speed of the patient.
See moreDiscover more
Similar signals
Similar public activity from other companies.
Presence & Recognition
Lunit Oncology
Lunit Oncology will present three studies at the 2026 World Conference on Lung Cancer in Seoul, showing how AI-based pathology analysis deepens understanding of the tumor microenvironment.
Presence & Recognition
Radformation
Radformation is hosting a gathering with the radiation oncology community at North Mississippi Medical Center Radiation Oncology in Tupelo, featuring insights on innovation and efficiency.
Presence & Recognition
Varian
Varian attended the ASTRO 2026 conference in Boston at the Siemens Healthineers booth to discuss FullScale, cloud hosted architecture, and evolving technology, operational, and financial models for radiation oncology.
Presence & Recognition
TheraPanacea
TheraPanacea is attending the ASTRO 2026 conference in Boston, Booth 538, from September 26 to 30.
Presence & Recognition
MVision AI